Precigen PGEN
NASDAQ PGEN
$7.11 -0.03 (-0.49%)
As of: Sep 4, 2026 · 3:59 PM EDT

Precigen (PGEN) Operating Margin (QoQ) (2012 - 2026)

Analysis

Precigen (PGEN) Operating Margin (QoQ) (2012 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Precigen 2.53 Bn 2.53 Bn 52.17 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 6,696.00
Mar 31, 2026 44,883.00
Dec 31, 2025 70,544.00
Sep 30, 2025 253,070.00
Jun 30, 2025 -202,574.00
Mar 31, 2025 71,129.00
Dec 31, 2024 -16,524.00
Sep 30, 2024 625,444.00
Jun 30, 2024 -619,348.00
Mar 31, 2024 49,495.00
Dec 31, 2023 -126,870.00
Sep 30, 2023 -32,303.00
Jun 30, 2023 7,315.00
Mar 31, 2023 -3,204.00
Dec 31, 2022 -119,083.00
Sep 30, 2022 78,449.00
Jun 30, 2022 -42,819.00
Mar 31, 2022 19,187.00
Dec 31, 2021 5,226.00
Sep 30, 2021 4,122.00